RE:RE:RE:RE:RE:Approx 3.5 million warrants expiring on August 14, 2024SAN DIEGO, CA and CALGARY, AB, August 14, 2019 -- Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC) (the “Company”), currently developing pelareorep, an intravenously delivered immunooncolytic virus, provides an update to confirm that its previously announced underwritten public offering of USD $3.7M (CDN $4.9M) was priced at USD $0.81 (CDN $1.07)
Each warrant has an exercise price of $0.90 per common share, is exercisable immediately and will expire 5 years from the date of issuance. The common shares and the accompanying warrants can only be purchased together in this Offering but will be issued separately.